Genesis Cancer and Blood Institute Announces Partnership with Sarah Cannon Research Institute to Expand Patient Access to Community-Based Clinical Research
Hot Springs, Ark., Sept. 22, 2021 – Genesis Cancer and Blood Institute (Genesis), a partner practice of American Oncology Network, LLC (AON), recently aligned with the Sarah Cannon Research Institute, a global leader in offering community-based clinical trials.
For close to 30 years, Genesis has been participating in clinical trials. This new partnership with Sarah Cannon Research Institute will provide patients access to an expanded menu of clinical trials in the community. Genesis’ physicians deliver the most advanced cancer treatments customized for each patient so they can achieve the best possible outcome. The practice offers convenient access to comprehensive treatments and support services close to where the patient lives. Having in-house laboratory, pathology and oral pharmacy services makes it easier for patients to receive the care they need in one location.
Genesis Medical Oncologist Dr. Timothy Webb said, “The significant progress made in treating cancer has predominantly come from scientific research. Clinical trials are designed to identify new, more effective therapies. This collaboration with Sarah Cannon Research Institute will expand patient access to the very latest in cancer care. It shows our commitment to not only improving the lives and the health of our patients but also the community.”
Genesis Medical Oncologist Dr. Stephen “Fred” Divers added, “Clinical trials and research provide a way to explore the most effective means to prevent, diagnose and treat cancer. Our partnership with Sarah Cannon Research Institute will provide our patients greater access to the latest advances available in the country, right here in Hot Springs.”
Genesis Medical Oncologists serving patients in Hot Springs are Dr. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. Lynn Cleveland and Dr. Lingyi Chen. Providing comprehensive cancer care in two central locations and eight satellite offices, Genesis also offers patients care management services through their affiliation with AON.
AON is an alliance of physicians and seasoned healthcare leaders that provides a unique array of enhanced services to its affiliated community-based oncology practices. It consistently strives to find innovative ways to connect with patients. AON’s community oncology model allows physicians to focus on what matters most — their patients.
About Genesis Cancer and Blood Institute: (GenesisCancerBlood.com)
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. S. Fred Divers, Dr. R. Tim Webb, Dr. Robert Muldoon, Dr. A. Lynn Cleveland and Dr. Lingyi Chen.
About Sarah Cannon Research Institute: (SarahCannon.com)
Sarah Cannon Research Institute is the research arm of HCA Healthcare’s Cancer Institute, Sarah Cannon. Focused on advancing therapies for patients, it is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. A leader in drug development, Sarah Cannon has led more than 500 first-in-human clinical trials since its inception in 1993, and has been a clinical trial leader in the majority of approved cancer therapies over the last 10 years. Additionally, Sarah Cannon offers management, regulatory, and other research support services for drug development and industry sponsors as well as strategic investigator sites through its contract research organization (CRO), Sarah Cannon Development Innovations.
About American Oncology Network, LLC: (AONcology.com)
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network currently represents 102 physicians and 75 nurse practitioners and physician assistants practicing across 17 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most – providing the highest quality care for patients.
The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per capita cost of cancer care.
AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences will be at the very pinnacle of cancer care today.
For More Information, Contact:
American Oncology Network, LLC
Vice President of Marketing